301 related articles for article (PubMed ID: 18389907)
1. Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge.
Klingström J; Stoltz M; Hardestam J; Ahlm C; Lundkvist A
Antivir Ther; 2008; 13(1):125-33. PubMed ID: 18389907
[TBL] [Abstract][Full Text] [Related]
2. Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques.
Klingström J; Falk KI; Lundkvist A
Arch Virol; 2005 Jan; 150(1):79-92. PubMed ID: 15449139
[TBL] [Abstract][Full Text] [Related]
3. Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome.
Pettersson L; Rasmuson J; Andersson C; Ahlm C; Evander M
J Med Virol; 2011 May; 83(5):864-70. PubMed ID: 21360546
[TBL] [Abstract][Full Text] [Related]
4. Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells.
Kallio-Kokko H; Leveelahti R; Brummer-Korvenkontio M; Lundkvist A ; Vaheri A; Vapalahti O
J Med Virol; 2001 Nov; 65(3):605-13. PubMed ID: 11596100
[TBL] [Abstract][Full Text] [Related]
5. Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment.
Pettersson L; Thunberg T; Rocklöv J; Klingström J; Evander M; Ahlm C
Clin Microbiol Infect; 2014 Mar; 20(3):235-41. PubMed ID: 23742660
[TBL] [Abstract][Full Text] [Related]
6. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome.
Evander M; Eriksson I; Pettersson L; Juto P; Ahlm C; Olsson GE; Bucht G; Allard A
J Clin Microbiol; 2007 Aug; 45(8):2491-7. PubMed ID: 17537944
[TBL] [Abstract][Full Text] [Related]
7. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
[TBL] [Abstract][Full Text] [Related]
8. Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome.
Korva M; Saksida A; Kejžar N; Schmaljohn C; Avšič-Županc T
Clin Microbiol Infect; 2013 Aug; 19(8):E358-66. PubMed ID: 23573903
[TBL] [Abstract][Full Text] [Related]
9. Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.
Klingström J; Plyusnin A; Vaheri A; Lundkvist A
J Virol; 2002 Jan; 76(1):444-9. PubMed ID: 11739712
[TBL] [Abstract][Full Text] [Related]
10. Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.
Klingström J; Smed-Sörensen A; Maleki KT; Solà-Riera C; Ahlm C; Björkström NK; Ljunggren HG
J Intern Med; 2019 May; 285(5):510-523. PubMed ID: 30663801
[TBL] [Abstract][Full Text] [Related]
11. Tnf-α expression and promoter sequences reflect the balance of tolerance/resistance to Puumala hantavirus infection in European bank vole populations.
Guivier E; Galan M; Salvador AR; Xuéreb A; Chaval Y; Olsson GE; Essbauer S; Henttonen H; Voutilainen L; Cosson JF; Charbonnel N
Infect Genet Evol; 2010 Dec; 10(8):1208-17. PubMed ID: 20691810
[TBL] [Abstract][Full Text] [Related]
12. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
Hooper JW; Josleyn M; Ballantyne J; Brocato R
Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
[TBL] [Abstract][Full Text] [Related]
13. Puumala hantavirus in Slovenia: analyses of S and M segment sequences recovered from patients and rodents.
Avsic-Zupanc T; Petrovec M; Duh D; Plyusnina A; Lundkvist A; Plyusnin A
Virus Res; 2007 Feb; 123(2):204-10. PubMed ID: 16997412
[TBL] [Abstract][Full Text] [Related]
14. Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.
Xiong HR; Li Q; Chen W; Liu DY; Ling JX; Liu J; Liu YJ; Zhang Y; Yang ZQ
Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):645-51. PubMed ID: 21222012
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
Zhao C; Sun Y; Zhao Y; Wang S; Yu T; Du F; Yang XF; Luo E
Hum Vaccin Immunother; 2012 Feb; 8(2):208-15. PubMed ID: 22426376
[TBL] [Abstract][Full Text] [Related]
16. Puumala virus in Croatia in the 2002 HFRS outbreak.
Cvetko L; Markotić A; Plyusnina A; Margaletić J; Miletić-Medved M; Turk N; Milas Z; Avsic-Zupanc T; Plyusnin A
J Med Virol; 2005 Oct; 77(2):290-4. PubMed ID: 16121366
[TBL] [Abstract][Full Text] [Related]
17. [Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia].
Cebalo L; Dusek T; Kuzman I; Markotić A
Acta Med Croatica; 2003; 57(5):355-9. PubMed ID: 15011460
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Puumala hantavirus outbreak in Black Sea Region, Turkey.
Çelebi G; Öztoprak N; Öktem İMA; Heyman P; Lundkvist Å; Wahlström M; Köktürk F; Pişkin N
Zoonoses Public Health; 2019 Nov; 66(7):783-797. PubMed ID: 31293096
[TBL] [Abstract][Full Text] [Related]
19. Genetic and antigenic analyses of a Puumala virus isolate as a potential vaccine strain.
Abu Daude NH; Kariwa H; Tkachenko E; Dzagurnova T; Medvedkina O; Tkachenko P; Ishizuka M; Seto T; Miyashita D; Sanada T; Nakauchi M; Yoshii K; Maeda A; Yoshimatsu K; Arikawa J; Takashima I
Jpn J Vet Res; 2008 Nov; 56(3):151-65. PubMed ID: 19177744
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a new immunochromatographic rapid test with a commercial EIA for the detection of Puumala virus specific IgM antibodies.
Hujakka H; Koistinen V; Eerikäinen P; Kuronen I; Laatikainen A; Kauppinen J; Vaheri A; Vapalahti O; Närvänen A
J Clin Virol; 2001 Dec; 23(1-2):79-85. PubMed ID: 11595586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
